import { GuideLayout } from "@/components/guides/GuideLayout";
import { QuickAnswerBox } from "@/components/guides/QuickAnswerBox";
import { BottomLineBox } from "@/components/guides/BottomLineBox";
import { GuideFAQ } from "@/components/guides/GuideFAQ";
import { GuideCTA } from "@/components/guides/GuideCTA";
import { GuideDisclaimer } from "@/components/guides/GuideDisclaimer";
import { RelatedGuides } from "@/components/guides/RelatedGuides";
import { GuideTableOfContents } from "@/components/guides/GuideTableOfContents";
import { SITE_URL } from "@/lib/seo";

const tocItems = [
  { id: "gastric-origin", title: "BPC-157's Origin in Gastric Juice", level: 2 },
  { id: "animal-gut-studies", title: "Animal Studies on Gut Healing", level: 2 },
  { id: "ibd-colitis", title: "IBD/Colitis Research (Animal)", level: 2 },
  { id: "ulcer-healing", title: "Ulcer Healing Studies", level: 2 },
  { id: "human-evidence", title: "Human Evidence (Currently None)", level: 2 },
  { id: "leaky-gut", title: "The 'Leaky Gut' Question", level: 2 },
  { id: "risks-gi", title: "Risks for GI Use", level: 2 },
  { id: "primary-sources", title: "Primary Sources", level: 2 },
  { id: "faq", title: "FAQ", level: 2 },
];

const faqItems = [
  {
    question: "Can BPC-157 cure IBS?",
    answer:
      "There is no scientific evidence that BPC-157 cures IBS in humans. IBS is a complex disorder with no single cure, and BPC-157 has never been studied in human IBS patients. Claims that it 'cures' IBS are not supported by clinical trials.",
  },
  {
    question: "Is oral BPC-157 effective for gut issues?",
    answer:
      "Some animal studies used oral BPC-157 and showed effects on gut healing, particularly for ulcers. This suggests oral administration may have localized GI effects. However, no human trials confirm oral BPC-157 works for any gut condition. Bioavailability and optimal dosing are unknown.",
  },
  {
    question: "How long to see gut healing results from BPC-157?",
    answer:
      "There is no established timeline because no human clinical trials exist. Animal studies showed effects over days to weeks, but this doesn't translate directly to humans. Anecdotal reports vary widely and are not reliable indicators of what to expect.",
  },
  {
    question: "Is BPC-157 better than probiotics for gut health?",
    answer:
      "This comparison cannot be made scientifically. Probiotics have human clinical trial evidence for certain gut conditions. BPC-157 has zero human trials for gut health. Probiotics are FDA-regulated as supplements with quality standards. BPC-157 is unregulated with no quality control.",
  },
];

const relatedGuides = [
  { title: "BPC-157: Complete Research Guide", href: "/guides/bpc-157-complete-guide" },
  { title: "Oral vs Injectable BPC-157", href: "/guides/oral-vs-injectable-bpc-157" },
  { title: "BPC-157 Side Effects", href: "/guides/bpc-157-side-effects" },
];

const articleSchema = {
  "@context": "https://schema.org",
  "@type": "Article",
  headline: "BPC-157 for Gut Health: IBS, Leaky Gut & IBD Research [2026]",
  description: "Evidence-based analysis of BPC-157 for gut healing. Animal study findings for IBD, ulcers, and intestinal healing. Why human evidence is missing.",
  datePublished: "2026-02-02",
  dateModified: "2026-02-02",
  author: {
    "@type": "Organization",
    name: "Peptide Playbook",
  },
  publisher: {
    "@type": "Organization",
    name: "Peptide Playbook",
    logo: {
      "@type": "ImageObject",
      url: `${SITE_URL}/logo.png`,
    },
  },
  mainEntityOfPage: {
    "@type": "WebPage",
    "@id": `${SITE_URL}/guides/bpc-157-gut-healing`,
  },
};

const faqSchema = {
  "@context": "https://schema.org",
  "@type": "FAQPage",
  mainEntity: faqItems.map((item) => ({
    "@type": "Question",
    name: item.question,
    acceptedAnswer: {
      "@type": "Answer",
      text: item.answer,
    },
  })),
};

export default function BPC157GutHealing() {
  return (
    <GuideLayout
      title="BPC-157 for Gut Health: IBS, Leaky Gut & IBD Research [2026]"
      description="Evidence-based analysis of BPC-157 for gut healing. Animal study findings for IBD, ulcers, and intestinal healing. Why human evidence is missing."
      slug="bpc-157-gut-healing"
      articleSchema={articleSchema}
      faqSchema={faqSchema}
    >
      <div className="flex gap-10">
        <GuideTableOfContents items={tocItems} />

        <article className="flex-1 max-w-3xl">
          <QuickAnswerBox
            answer="BPC-157 was originally isolated from gastric juice, and animal studies show effects on gut healing, including IBD models and ulcer healing in rats. However, there are no published human trials for IBS, leaky gut, or IBD. The 'gut healing' claims you see online are extrapolations from animal data, not proven human outcomes."
            lastUpdated="February 2, 2026"
            readTime="10 minutes"
          />

          <h1 className="text-3xl md:text-4xl font-bold mb-8">
            BPC-157 for Gut Health: IBS, Leaky Gut & IBD Research
          </h1>

          <section id="gastric-origin" className="mb-10">
            <h2 className="text-2xl font-bold mb-4">BPC-157's Origin in Gastric Juice</h2>
            <p className="text-muted-foreground mb-4 leading-relaxed">
              BPC-157 (Body Protection Compound-157) is derived from a protein naturally found in human gastric juice. This origin is why researchers initially investigated it for gastrointestinal applications.
            </p>
            <p className="text-muted-foreground mb-4 leading-relaxed">
              The peptide consists of 15 amino acids and is a fragment of a larger protein involved in digestive processes. Early research focused on its potential "cytoprotective" (cell-protecting) effects in the GI tract.
            </p>
            <div className="p-4 bg-primary/5 border-l-4 border-primary rounded-r-lg">
              <p className="text-sm font-medium">
                <strong>Important context:</strong> While BPC-157 comes from gastric juice, the synthetic version used in research is not identical to what exists naturally. Its effects may differ from natural gastric proteins.
              </p>
            </div>
          </section>

          <section id="animal-gut-studies" className="mb-10">
            <h2 className="text-2xl font-bold mb-4">Animal Studies on Gut Healing</h2>
            <p className="text-muted-foreground mb-4 leading-relaxed">
              Multiple animal studies have examined BPC-157's effects on the gastrointestinal tract, primarily in rats.
            </p>
            
            <h3 className="text-xl font-semibold mb-3">Key Findings (Animal Models):</h3>
            <ul className="list-disc list-inside text-muted-foreground mb-4 space-y-2">
              <li>Accelerated healing of experimentally-induced gastric ulcers</li>
              <li>Reduced damage from NSAID-induced gastric lesions</li>
              <li>Improved healing of intestinal anastomoses (surgical connections)</li>
              <li>Protective effects against alcohol-induced gastric damage</li>
              <li>Reduced inflammation in some colitis models</li>
            </ul>

            <h3 className="text-xl font-semibold mb-3">Proposed Mechanisms:</h3>
            <ul className="list-disc list-inside text-muted-foreground mb-4 space-y-2">
              <li>Enhancement of nitric oxide system</li>
              <li>Promotion of angiogenesis (blood vessel formation)</li>
              <li>Modulation of growth factors</li>
              <li>Anti-inflammatory effects</li>
            </ul>

            <div className="p-4 bg-muted rounded-lg">
              <p className="text-sm text-muted-foreground">
                <strong className="text-foreground">Limitation:</strong> Rat GI tracts differ from human GI tracts in important ways. Positive results in rodents frequently fail to replicate in human trials.
              </p>
            </div>
          </section>

          <section id="ibd-colitis" className="mb-10">
            <h2 className="text-2xl font-bold mb-4">IBD/Colitis Research (Animal)</h2>
            <p className="text-muted-foreground mb-4 leading-relaxed">
              Several studies have examined BPC-157 in animal models of inflammatory bowel disease (IBD), including experimental colitis.
            </p>
            
            <h3 className="text-xl font-semibold mb-3">Study Findings:</h3>
            <ul className="list-disc list-inside text-muted-foreground mb-4 space-y-2">
              <li>Reduced severity of colitis symptoms in rat models</li>
              <li>Decreased inflammatory markers</li>
              <li>Improved mucosal healing</li>
              <li>Protection against colonic damage from various agents</li>
            </ul>

            <h3 className="text-xl font-semibold mb-3">What This Does NOT Prove:</h3>
            <ul className="list-disc list-inside text-muted-foreground mb-4 space-y-2">
              <li>BPC-157 treats human IBD (Crohn's or ulcerative colitis)</li>
              <li>Safe or effective dosing for humans with IBD</li>
              <li>Long-term effects in chronic GI conditions</li>
              <li>Interaction with IBD medications</li>
            </ul>

            <div className="p-4 bg-primary/5 border-l-4 border-primary rounded-r-lg">
              <p className="text-sm font-medium">
                <strong>Reality check:</strong> Many substances improve experimental colitis in mice but fail to help human IBD. The gap between animal models and human disease is significant.
              </p>
            </div>
          </section>

          <section id="ulcer-healing" className="mb-10">
            <h2 className="text-2xl font-bold mb-4">Ulcer Healing Studies</h2>
            <p className="text-muted-foreground mb-4 leading-relaxed">
              Ulcer healing is one of the most studied applications of BPC-157 in animal research.
            </p>
            
            <h3 className="text-xl font-semibold mb-3">Types of Ulcers Studied (in Animals):</h3>
            <ul className="list-disc list-inside text-muted-foreground mb-4 space-y-2">
              <li>Gastric (stomach) ulcers</li>
              <li>Duodenal ulcers</li>
              <li>Esophageal lesions</li>
              <li>NSAID-induced ulcers</li>
              <li>Stress-induced ulcers</li>
            </ul>

            <h3 className="text-xl font-semibold mb-3">Observed Effects:</h3>
            <ul className="list-disc list-inside text-muted-foreground mb-4 space-y-2">
              <li>Faster ulcer closure</li>
              <li>Improved tissue regeneration</li>
              <li>Protection when given before ulcer-inducing agents</li>
            </ul>

            <p className="text-muted-foreground leading-relaxed">
              <strong>Note:</strong> Proven ulcer treatments exist (PPIs, H2 blockers, antibiotics for H. pylori). These have extensive human trial data that BPC-157 lacks.
            </p>
          </section>

          <section id="human-evidence" className="mb-10">
            <h2 className="text-2xl font-bold mb-4">Human Evidence: Currently None</h2>
            <p className="text-muted-foreground mb-4 leading-relaxed">
              Despite the animal research, there are no published human clinical trials examining BPC-157 for any gut condition.
            </p>
            
            <h3 className="text-xl font-semibold mb-3">Status of Human Research:</h3>
            <div className="overflow-x-auto mb-4">
              <table className="w-full text-sm border border-border rounded-lg overflow-hidden">
                <thead className="bg-muted">
                  <tr>
                    <th className="text-left p-3 font-semibold">Condition</th>
                    <th className="text-left p-3 font-semibold">Human Trials</th>
                  </tr>
                </thead>
                <tbody>
                  <tr className="border-t border-border">
                    <td className="p-3 font-medium">IBS</td>
                    <td className="p-3 text-muted-foreground">None</td>
                  </tr>
                  <tr className="border-t border-border">
                    <td className="p-3 font-medium">IBD (Crohn's, UC)</td>
                    <td className="p-3 text-muted-foreground">None</td>
                  </tr>
                  <tr className="border-t border-border">
                    <td className="p-3 font-medium">Gastric ulcers</td>
                    <td className="p-3 text-muted-foreground">None</td>
                  </tr>
                  <tr className="border-t border-border">
                    <td className="p-3 font-medium">Leaky gut</td>
                    <td className="p-3 text-muted-foreground">None</td>
                  </tr>
                  <tr className="border-t border-border">
                    <td className="p-3 font-medium">GERD</td>
                    <td className="p-3 text-muted-foreground">None</td>
                  </tr>
                </tbody>
              </table>
            </div>

            <div className="p-4 bg-primary/5 border-l-4 border-primary rounded-r-lg">
              <p className="text-sm font-medium">
                <strong>The gap:</strong> Claims that BPC-157 "heals" gut conditions are extrapolations from animal studies, not proven human outcomes.
              </p>
            </div>
          </section>

          <section id="leaky-gut" className="mb-10">
            <h2 className="text-2xl font-bold mb-4">The "Leaky Gut" Question</h2>
            <p className="text-muted-foreground mb-4 leading-relaxed">
              "Leaky gut" (increased intestinal permeability) is a popular concept in wellness circles, often cited as a target for BPC-157.
            </p>
            
            <h3 className="text-xl font-semibold mb-3">What We Know:</h3>
            <ul className="list-disc list-inside text-muted-foreground mb-4 space-y-2">
              <li>Intestinal permeability is a real, measurable phenomenon</li>
              <li>It's associated with certain conditions (celiac disease, IBD, severe burns)</li>
              <li>"Leaky gut syndrome" as a cause of systemic disease remains controversial</li>
            </ul>

            <h3 className="text-xl font-semibold mb-3">BPC-157 and Intestinal Permeability:</h3>
            <ul className="list-disc list-inside text-muted-foreground mb-4 space-y-2">
              <li>Some animal studies suggest effects on gut barrier function</li>
              <li>No human studies measuring intestinal permeability with BPC-157</li>
              <li>Claims of "healing leaky gut" are not supported by human evidence</li>
            </ul>
          </section>

          <section id="risks-gi" className="mb-10">
            <h2 className="text-2xl font-bold mb-4">Risks for GI Use</h2>
            
            <h3 className="text-xl font-semibold mb-3">Unknown Factors:</h3>
            <ul className="list-disc list-inside text-muted-foreground mb-4 space-y-2">
              <li>Safe dosing for GI conditions (never established)</li>
              <li>Oral bioavailability and optimal formulation</li>
              <li>Interaction with GI medications (PPIs, immunosuppressants, biologics)</li>
              <li>Effects on gut microbiome</li>
              <li>Long-term effects on GI tract</li>
            </ul>

            <h3 className="text-xl font-semibold mb-3">Potential Concerns:</h3>
            <ul className="list-disc list-inside text-muted-foreground space-y-2">
              <li>Delaying proven treatments while using unproven therapies</li>
              <li>Contaminated products causing GI symptoms</li>
              <li>Missing serious GI conditions that need proper diagnosis</li>
            </ul>
          </section>

          <section id="primary-sources" className="mb-10">
            <h2 className="text-2xl font-bold mb-4">Primary Sources</h2>
            <ul className="list-disc list-inside text-muted-foreground space-y-2">
              <li>
                <a href="https://pubmed.ncbi.nlm.nih.gov/" target="_blank" rel="noopener noreferrer" className="text-primary hover:underline">
                  PubMed: BPC-157 Gastric Protection Studies
                </a>
              </li>
              <li>
                <a href="https://pubmed.ncbi.nlm.nih.gov/" target="_blank" rel="noopener noreferrer" className="text-primary hover:underline">
                  PubMed: BPC-157 Colitis Studies (Animal)
                </a>
              </li>
              <li>
                <a href="https://www.fda.gov/drugs/human-drug-compounding/bulk-drug-substances-used-compounding" target="_blank" rel="noopener noreferrer" className="text-primary hover:underline">
                  FDA: Bulk Drug Substances in Compounding
                </a>
              </li>
            </ul>
          </section>

          <section id="faq">
            <GuideFAQ items={faqItems} />
          </section>

          <BottomLineBox content="BPC-157 originated from gastric juice and has shown gut-healing effects in animal studies for ulcers, colitis, and intestinal damage. However, there are zero human clinical trials for IBS, IBD, leaky gut, or any gut condition. The 'gut healing' claims online are extrapolations from animal data. Proven GI treatments exist with extensive human evidence that BPC-157 lacks." />

          <RelatedGuides guides={relatedGuides} />

          <GuideCTA />

          <GuideDisclaimer />
        </article>
      </div>
    </GuideLayout>
  );
}
